Literature DB >> 31471910

Toward evidence-based severity assessment in rat models with repeated seizures: II. Chemical post-status epilepticus model.

Ines Koska1, Roelof Maarten van Dijk1, Isabel Seiffert1, Valentina Di Liberto1,2, Christina Möller1, Rupert Palme3, Rainer Hellweg4, Heidrun Potschka1.   

Abstract

OBJECTIVE: Considering the complexity of neuronal circuits and their epilepsy-associated alterations, epilepsy models cannot be completely replaced by in vitro experimental approaches. Decisions about ethical approval of in vivo studies require a thorough weighing of the animal's burden and the benefit regarding the expected gain in knowledge.
METHODS: Based on combined behavioral, biochemical, and physiological analyses, we assessed the impact on animal well-being and condition in different phases of the pilocarpine post-status epilepticus (SE) model in rats.
RESULTS: As a consequence of SE, increased levels of impairment were evident in the early postinsult phase and late chronic phase, whereas only mild impairment was observed in the interim phase. Parameters that stood out as sensitive indicators of animal distress include burrowing, which proved to be affected throughout all experimental phases, saccharin preference, fecal corticosterone metabolites, heart rate, and heart rate variability. SIGNIFICANCE: The cumulative burden with temporary but not long-lasting phases of more pronounced impairment suggests a classification of severe as a basis for laboratory-specific prospective and retrospective evaluation. Among the parameters analyzed, burrowing behavior and saccharin preference stand out as candidate parameters that seem to be well suited to obtain information about animal distress in epileptogenesis models.
© 2019 The Authors. Epilepsia published by Wiley Periodicals, Inc. on behalf of International League Against Epilepsy.

Entities:  

Keywords:  3R; behavior; pilocarpine; rodent; stress

Mesh:

Substances:

Year:  2019        PMID: 31471910     DOI: 10.1111/epi.16330

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  6 in total

1.  Comparative Severity Assessment of Genetic, Stress-Based, and Pharmacological Mouse Models of Depression.

Authors:  Anne Stephanie Mallien; Natascha Pfeiffer; Christiane Brandwein; Dragos Inta; Rolf Sprengel; Rupert Palme; Steven R Talbot; Peter Gass
Journal:  Front Behav Neurosci       Date:  2022-06-16       Impact factor: 3.617

2.  Development of behavioral patterns in young C57BL/6J mice: a home cage-based study.

Authors:  Maria Reiber; Ines Koska; Claudia Pace; Katharina Schönhoff; Lara von Schumann; Rupert Palme; Heidrun Potschka
Journal:  Sci Rep       Date:  2022-02-15       Impact factor: 4.379

3.  The impact of tethered recording techniques on activity and sleep patterns in rats.

Authors:  Katharina Aulehner; Jack Bray; Ines Koska; Claudia Pace; Rupert Palme; Matthias Kreuzer; Bettina Platt; Thomas Fenzl; Heidrun Potschka
Journal:  Sci Rep       Date:  2022-02-24       Impact factor: 4.379

4.  Dopamine Transporter Knockout Rats Show Impaired Wellbeing in a Multimodal Severity Assessment Approach.

Authors:  Anne Stephanie Mallien; Laura Becker; Natascha Pfeiffer; Federica Terraneo; Melissa Hahn; Anthonieke Middelman; Rupert Palme; Kerstin Camile Creutzberg; Veronica Begni; Marco Andrea Riva; Damiana Leo; Heidrun Potschka; Fabio Fumagalli; Judith R Homberg; Peter Gass
Journal:  Front Behav Neurosci       Date:  2022-07-11       Impact factor: 3.617

5.  Design of composite measure schemes for comparative severity assessment in animal-based neuroscience research: A case study focussed on rat epilepsy models.

Authors:  Roelof Maarten van Dijk; Ines Koska; Andre Bleich; Rene Tolba; Isabel Seiffert; Christina Möller; Valentina Di Liberto; Steven Roger Talbot; Heidrun Potschka
Journal:  PLoS One       Date:  2020-05-15       Impact factor: 3.240

6.  Social isolation in rats: Effects on animal welfare and molecular markers for neuroplasticity.

Authors:  Veronica Begni; Alice Sanson; Natascha Pfeiffer; Christiane Brandwein; Dragos Inta; Steven R Talbot; Marco Andrea Riva; Peter Gass; Anne Stephanie Mallien
Journal:  PLoS One       Date:  2020-10-27       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.